Pfizer CEO: Transforming Drug Discovery, Lessons from China and Leading with Optimism
Nicolai Tangen meets Pfizer CEO Albert Bourla for a wide-ranging conversation on leadership, science, and the future of global healthcare. Bourla reflects on leading Pfizer through the COVID-19 vaccine breakthrough and how it transformed the company. The discussion also dives into Pfizer’s strategic shift toward…
We score an episode from what we can actually measure — its reach and engagement, what listeners say about it, and what it covers. We don't have those signals for this one yet, so it doesn't get a number.
Buzzmeter says it's buzzing across platforms — the Hive Vote says whether the people who actually listened liked it.
Rate this episode
Add your vote to the Hive — listeners rate every episode after they finish.
- No reviews yet — be the first.
More from In Good Company with Nicolai Tangen
See all episodes →
43%Venki Ramakrishnan: The Science and Hype of Living Longer
41%Eliot Higgins: How Bellingcat Hunts Down the Truth
39%Horizon Robotics CEO: Car Chips, Mind-Off Driving and China's Speed
Similar episodes from other shows
More like In Good Company with Nicolai Tangen →
Novartis CEO Vasant Narasimhan on Transforming a 250-Year-Old Company
The $2 Trillion Mind | Nicolai Tangen
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
Moderna's CFO on How to Allocate Capital in Big Pharma
One great episode in your inbox, daily — free.
One email a day, unsubscribe anytime. No spam, ever.